| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director | Chief Executive Officer
2 companies
Gibson Christopher is a Director at RECURSION PHARMACEUTICALS, INC. with holdings across 2 companies. Recent SEC Form 4 filings include 0 buys and 13 sells.
Estimated insider holdings value: $3.0M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jan 31, 2022 | RXRX Recursion Pharmaceuticals, Inc. | Chief Executive Officer | Sell | 19,858 | $11.73 | $232,964.13 | -45.8% | -44.2% | -29.6% | |
| Jan 14, 2022 | RXRX Recursion Pharmaceuticals, Inc. | Chief Executive Officer | Sell | 341,000 | $13.76 | $4,692,177.31 | -81.2% | -46.0% | -37.0% | |
| Dec 16, 2021 | RXRX Recursion Pharmaceuticals, Inc. | Chief Executive Officer | Sell | 200 | $20.01 | $4,001.00 | -0.8% | -62.9% | -52.4% | |
| Dec 13, 2021 | RXRX Recursion Pharmaceuticals, Inc. | Chief Executive Officer | Sell | 100 | $20.02 | $2,001.50 | -0.4% | -68.3% | -54.5% | |
| Dec 9, 2021 | RXRX Recursion Pharmaceuticals, Inc. | Chief Executive Officer | Sale+OE | 11,750 | $20.13 | $236,562.17 | -14.3% | -59.1% | -54.2% | |
| Dec 7, 2021 | RXRX Recursion Pharmaceuticals, Inc. | Chief Executive Officer | Sell | 19,792 | $20.48 | $405,432.76 | -0.1% | -65.8% | -55.0% |